EP3880802 - Bibliographic data
PROCÉDÉ AMÉLIORÉ DE FABRICATION DE LYMPHOCYTES T
| Last update | 10/07/2025 |
|---|---|
| Legal status | Brevet délivré |
| Origin | Euro-PCT |
| (73) Holder |
Celgene Corporation Route 206 & Province Line Road
Princeton, NJ 08543
États-Unis d'Amérique
|
|---|---|
| (72) Inventors |
Thomas BRIEVA 14 Country Lane
Manalapan, NJ 07726
États-Unis d'Amérique
David HSIUNG 201 Montgomery Street, Apt. 638
Jersey City, NJ 07302
États-Unis d'Amérique
Seth JONES 318 Stratford Place
Bound Brook, NJ 08805
États-Unis d'Amérique
Shiv MISTRY 106 Penobscot Street
Clifton, NJ 07013
États-Unis d'Amérique
Nayyereh RAJAEI 191 Lindsey Court
Franklin Park, NJ 08823
États-Unis d'Amérique
|
| (74) Agent |
Mail recipient Mewburn Ellis LLP Aurora Building
Counterslip
Bristol BS1 6BX
Royaume-Uni
|
| (21) Request number | EP19821337.3 |
|---|---|
| (22) Request date | 15/11/2019 |
| (11) Publication number | EP3880802 |
|---|---|
| Publication date | 07/09/2022 |
| (54) Title of the invention | PROCÉDÉ AMÉLIORÉ DE FABRICATION DE LYMPHOCYTES T |
|---|---|
| (51) International classification | A61K 38/00, C07K 14/725, C12N 5/0783, C07K 14/705, A61K 48/00 |
| International classification (before reform) | None |
| Claimed priority |
(31) Number: 201862768579 P |
|---|---|
| Initial application | None |
| Divisional application | EP22191002.9 /EP4151722 None |
| Expected annuity | Annuity: 7 - Amount: 150 € - Due date 01/12/2025 |
|---|---|
| Last annuity | Annuity: 6 - Payment date 29/10/2024 |
| Publication | None |
|---|---|
| History | Publication de la délivrance du brevet européen - Legal date 07/09/2022 Modification du mandataire OEB du brevet européen - Legal date 02/02/2024 Modification des titulaires du brevet européen - Legal date 01/03/2024 |